Issue and repurchase of series C shares for performance-based share saving program
Pursuant to the authorization granted by the annual general meeting on 1 June 2021, the board of directors of Alligator Bioscience AB (”Alligator”) has resolved to issue and immediately thereafter repurchase 949,850 series C shares. The shares are issued and repurchased in accordance with the performance-based share saving program LTI 2021, which was adopted by the annual general meeting on 1 June 2021. Pursuant to the authorization granted by the annual general meeting on 1 June 2021, the board of directors of Alligator has resolved on a directed issue of 949,850 series C shares to DNB